Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
English
Regional settings
Entity•Capital Com UK LimitedAuthorised and regulated by the Financial Conduct Authority (FCA)
Why Capital.com?
About us
Our history
Our offices
Leadership team
Client funds
How Capital.com makes money
Contact us
Terms and policies
Ways to trade
CFD trading
Spread betting
1X
Charges and fees
Professional
Margin Calls
Markets
Shares
Forex
Indices
Commodities
Trading platforms 
Web platform
Mobile apps
MT4
TradingView
Demo
Learn to trade
Essentials of trading
Risk-management guide
Market guides
Trading Strategies
Trading Psychology
Technical analysis
Market analysis
Help
My account

HomeMarketsSharesAstraZeneca PLC - SEK

Trade AstraZeneca PLC - SEK - AZNs CFD

SummaryHistorical Data
Trading Conditions
Spread5.3
Long position overnight fee
Long position overnight fee
Margin. Your investment
SEK 1,000.00
Overnight fee
Charges from full value of position
-0.021938 %
(-SEK 0.90)

Trade size with leverage ~ SEK 5,000.00

Short position overnight fee ~ SEK 4,000.00

-0.021938%
Short position overnight fee
Short position overnight fee
Margin. Your investment
SEK 1,000.00
Overnight fee
Charges from full value of position
-0.000284 %
(-SEK 0.00)

Trade size with leverage ~ SEK 5,000.00

Short position overnight fee ~ SEK 4,000.00

-0.000284%
Overnight fee time21:00 (UTC)
CurrencySEK
Min traded quantity1
Margin20
Stock exchangeSweden
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close1652.6
Open1647.6
1-Year Change9.38%
Day's Range1647.6 - 1668.6

AstraZeneca - SEK Company profile

AstraZeneca is a multinational biopharmaceutical company that resulted from the merger between the Swedish Astra AB and the English Zeneca Group in 1999. The company is engaged in developing and manufacturing products to treat oncology, cardiovascular & metabolic disease (CVMD) and pursues therapies in autoimmunity, infection and neuroscience. Its R&D headquarters are located in Warsaw, Poland, while its corporate base is in London, England. AstraZeneca is listed on the stock exchanges in London, New York and Stockholm under the ticker AZN. The AZN stock belongs to the FTSE 100 Index. Follow the latest developments of the AstraZeneca share price at Capital.com.